Metastatic sites and lesion numbers cooperated to predict efficacy of PD‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer

BACKGROUND: Limited data have been used to evaluate the efficacy of immunotherapy in metastatic colorectal cancer (mCRC). Furthermore, potential markers that can be used to identify responding patients and to further improve efficacy have not been fully explored. METHODS AND RESULTS: In our study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Weiqin, He, Yinjun, He, Wenguang, Zhang, Xiang, Chen, Nan, Li, Yandong, Zhong, Weixiang, Wu, Guosheng, Zhou, Xile, Hua, Hanju, Ye, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278516/
https://www.ncbi.nlm.nih.gov/pubmed/37081776
http://dx.doi.org/10.1002/cam4.5959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278516/
https://www.ncbi.nlm.nih.gov/pubmed/37081776
http://dx.doi.org/10.1002/cam4.5959

Ejemplares similares